ArticleNeuro-oncology2019

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

Romain Appay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.